a biotechnology company, which specializes in transformational treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases.
Industry Biotechnology
A.I.dvisor indicates that over the last year, AKRO has been loosely correlated with ETNB. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if AKRO jumps, then ETNB could also see price increases.
Ticker / NAME | Correlation To AKRO | 1D Price Change % | ||
---|---|---|---|---|
AKRO | 100% | +4.72% | ||
ETNB - AKRO | 63% Loosely correlated | +1.01% | ||
DNLI - AKRO | 46% Loosely correlated | -0.30% | ||
PLRX - AKRO | 44% Loosely correlated | +4.74% | ||
BEAM - AKRO | 44% Loosely correlated | -1.21% | ||
IDYA - AKRO | 42% Loosely correlated | +1.07% | ||
More |